Cargando…
Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma
Peroxisome proliferator-activated receptor-gamma (PPARγ) is a transcription factor drugable by agonists approved for treatment of type 2 diabetes, but also inhibits carcinogenesis and cell proliferation in vivo. Activating mutations in the Kirsten rat sarcoma viral oncogene homologue (KRAS) gene mit...
Autores principales: | Weidner, Philip, Söhn, Michaela, Schroeder, Torsten, Helm, Laura, Hauber, Veronika, Gutting, Tobias, Betge, Johannes, Röcken, Christoph, Rohrbacher, Florian N., Pattabiraman, Vijaya R., Bode, Jeffrey W., Seger, Rony, Saar, Daniel, Nunes-Alves, Ariane, Wade, Rebecca C., Ebert, Matthias P. A., Burgermeister, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286916/ https://www.ncbi.nlm.nih.gov/pubmed/32522977 http://dx.doi.org/10.1038/s41389-020-0238-8 |
Ejemplares similares
-
Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer
por: Weidner, Philip, et al.
Publicado: (2016) -
PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008) -
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells
por: Gutting, Tobias, et al.
Publicado: (2021) -
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
por: Meindl-Beinker, Nadja M., et al.
Publicado: (2019) -
Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer
por: Friedrich, Teresa, et al.
Publicado: (2016)